Found vs Omzo: Personalized GLP-1 Care and Pricing Compared
Found vs Omzo compares two telehealth approaches to GLP-1 and weight management care. Quick verdict: Found emphasizes a biology-first, medically supervised program with affordable monthly plans starting at $39, while Omzo focuses on clinician-guided compounded semaglutide and tirzepatide with pricing starting at $179.
Explore Found membership starting at $39
How they differ at a glance
Both platforms connect patients with clinical oversight and offer compounded GLP-1 options, but the most distinctive differences are approach to care, pricing and plans, medication options and regulation notes, and insurance handling. Below we compare these elements directly using only supplied facts.
Comparison table
| Criteria | Found | Omzo |
|---|---|---|
| Primary approach | Biology-first, personalized medically supervised program | Clinician-guided GLP-1 care with licensed providers |
| Starting price | Starting at $39 | Starting at $179 |
| Medication options | Semaglutide and tirzepatide; compounded options noted | Compounded semaglutide and tirzepatide; may prescribe branded meds but Omzo does not sell or ship branded |
| Insurance and payment | Most insurance now accepted; Found handles insurance paperwork; Medicare programs noted | FSA and HSA eligible; patient responsible for filling branded prescriptions and costs |
| Regulatory note | Compounded GLP-1s are not FDA-approved and not evaluated for safety or efficacy | Compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness or quality |
Approach to care: biology-first versus clinician-guided
Found positions itself as biology-first, emphasizing a comprehensive medical evaluation that builds a program around hormones, blood sugar regulation, sleep, and behavioral factors. Omzo describes clinician-guided plans where licensed U.S. providers review care and make prescribing decisions. Both use clinical review, but Found highlights a broader metabolic focus while Omzo emphasizes the licensed clinician decision process.
See Omzo clinician-guided GLP-1 plans
Pricing and payment differences
Pricing is a clear differentiator in the evidence. Found advertises getting started for as low as $39 and calls out affordable monthly plans and flexible pricing. Omzo lists semaglutide starting at $179 and tirzepatide starting at $279. Found also details multiple pricing notes including membership tiers and offers tied to insurance and Medicare programs. Omzo includes payment within its fees for compounded medication orders and notes product costs are included in fees collected by Omzo.
Review Found pricing and membership options
Medication sourcing, compounded status, and regulatory notes
Both providers offer compounded GLP-1 medications and include regulatory cautions. Found explicitly states compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy and are not available in all states. Omzo states its compounded medications are prepared by state-licensed sterile compounding pharmacies and are not FDA-approved, and notes branded prescriptions, if issued, must be filled by patients at their chosen pharmacy. Neither source guarantees results and both preserve that individual results may vary.
Insurance, shipping, and logistics
Found states most insurance is now accepted, that it handles insurance paperwork, and describes specific Medicare-related programs and pricing options, while noting coverage, pricing and terms vary and Rx is subject to provider review and clinical eligibility. Omzo notes FSA and HSA eligibility and that medication costs are included in the fees Omzo collects and that shipping and pharmacy capacity can affect rates. Omzo also notes it does not sell or ship branded medications.
Making the choice: Found vs Omzo
In short, Found positions itself for people seeking a biology-first, medically supervised program with low entry pricing and insurance handling, while Omzo is a clinician-guided platform focused on compounded semaglutide and tirzepatide with higher starting prices but clinician-led prescribing and pharmacy coordination. Both note compounded medications are not FDA-approved and that final prescriptions are subject to provider review and clinical eligibility.
Compare Omzo medication options and clinician review
Choose Found if…
You want a biology-first, personalized medically supervised weight loss program, lower starting pricing and assistance with insurance paperwork. Found emphasizes targeting hormones, metabolism, sleep and behavior and offers plans starting as low as $39 with most insurance accepted.
Choose Omzo if…
You prefer clinician-guided GLP-1 care focused on compounded semaglutide or tirzepatide with medication fees included in platform payments, and you will confirm eligibility, state availability and renewal terms before enrollment.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →